EMA committee recommends approval of an expanded indication for Merck’s Winrevair in adults with pulmonary arterial hypertension: Rahway, New Jersey Monday, December 15, 2025, 1 ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

A66-year-old man consulted his family physician because of progressive dyspnea. He had a history of hypertension and dyslipidemia, but no personal or family history of cardiac or respiratory diseases.

What Is Pulmonary Vascular Disease? The definition of pulmonary vascular disease is simple: any condition that affects the blood vessels along the route between the heart and lungs. Blood travels from ...

Pulmonary arterial hypertension (PAH) is a rare, progressive disease that often leads to right heart failure and premature death. Despite increased awareness and an expanding treatment landscape in ...

Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic ...

Pulmonary atresia is a congential condition (a condition present at birth) that affects a newborn’s heart. It limits blood flow from the heart to the lungs. A baby with this condition may need surgery ...

This case report describes a woman in her late 50s with reversible pulmonary hypertension (PH) due to scurvy, a rare vitamin ...